Mitochondria-localized fluorescent BODIPY-platinum conjugate

ACS Medicinal Chemistry Letters

Volumn 6, Issue 4, 2015, Pages 430-433

  Sun, Tingting ^a,b   Guan, Xingang ^a,c   Zheng, Min ^d   Jing, Xiabin ^a   Xie, Zhigang ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c BEIHUA UNIVERSITY   (China)

^d CHANGCHUN INSTITUTE OF OPTICS   (China)

Author keywords

BODIPY; cisplatin; imaging; mitochondria

Indexed keywords

1,3,5,7 TETRAMETHYL 8 (4 PYRIDYL) 4,4' DIFLUOROBORADIAZAINDACENE; CISPLATIN; FLUORESCENT DYE; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CYTOTOXICITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 84927632622     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.5b00041     Document Type: Article

References (35)

1. Naik, A.; Rubbiani, R.; Gasser, G.; Spingler, B. VisibleLight Induced Annihilation of Tumor Cells with Pt-Porphyrin Conjugates Angew. Chem., Int. Ed. 2014, 53, 6938-6941
2. Jamieson, E. R.; Lippard, S. J. Structure, Recognition, and Processing of Cisplatin-DNA Adducts Chem. Rev. 1999, 99, 2467-2498
3. Thayer, A. M. Pt drugs take their roll Chem. Eng. News 2010, 88, 24-28
4. Lease, N.; Vasilevski, V.; Carreira, M.; de Almeida, A.; Sanau, M.; Hirva, P.; Casini, A.; Contel, M. Potential anticancer heterometallic Fe-Au and Fe-Pd agents: initial mechanistic insights J. Med. Chem. 2013, 56, 5806-5818
5. Xiao, H.; Qi, R.; Liu, S.; Hu, X.; Duan, T.; Zheng, Y.; Huang, Y.; Jing, X. Biodegradable polymer-cisplatin(IV) conjugate as a pro-drug of cisplatin(II) Biomaterials 2011, 32, 7732-7739
6. Madias, N. E.; Harrington, J. T. Pt nephrotoxicity Am. J. Med. 1978, 65, 307-314
7. Ekborn, A.; Laurell, G.; Andersson, A.; Wallin, I.; Eksborg, S.; Ehrsson, H. Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig Hear. Res. 2000, 140, 38-44
8. Cheng, Q.; Shi, H.; Wang, H.; Min, Y.; Wang, J.; Liu, Y. The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells Chem. Commun. 2014, 50, 7427-7430
9. Pathak, R. K.; Marrache, S.; Choi, J. H.; Berding, T. B.; Dhar, S. The prodrug platin-A: simultaneous release of cisplatin and aspirin Angew. Chem. 2014, 53, 1963-1967
10. Vik, R.; Busnelli, M.; Parolini, C.; Bjorndal, B.; Holm, S.; Bohov, P.; Halvorsen, B.; Brattelid, T.; Manzini, S.; Ganzetti, G. S.; Dellera, F.; Nygard, O. K.; Aukrust, P.; Sirtori, C. R.; Chiesa, G.; Berge, R. K. An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-Atherosclerotic Effect beyond Plasma Cholesterol-Lowering Activity in apoE-/- Mice PLoS One 2013, 8, e81963
11. Lane, N. Mitochondrial disease: Powerhouse of disease Nature 2006, 440, 600-602
12. Tranah, G. J.; Yokoyama, J. S.; Katzman, S. M.; Nalls, M. A.; Newman, A. B.; Harris, T. B.; Cesari, M.; Manini, T. M.; Schork, N. J.; Cummings, S. R.; Liu, Y.; Yaffe, K. Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans Neurobiol. Aging 2014, 35, 442.e1-442.e8
13. Ten, V. S.; Yao, J.; Ratner, V.; Sosunov, S.; Fraser, D. A.; Botto, M.; Sivasankar, B.; Morgan, B. P.; Silverstein, S.; Stark, R.; Polin, R.; Vannucci, S. J.; Pinsky, D.; Starkov, A. A. Complement Component C1q Mediates Mitochondria-Driven Oxidative Stress in Neonatal Hypoxic-Ischemic Brain Injury J. Neurosci. 2010, 30, 2077-2087
14. Han, J.; Lee, T. H.; Tung, C.-H.; Lee, D. Y. Design and synthesis of a mitochondria-targeting carrier for small molecule drugs Org. Biomol. Chem. 2014, 12, 9793-9796
15. Chamberlain, G. R.; Tulumello, D. V.; Kelley, S. O. Targeted Delivery of Doxorubicin to Mitochondria ACS Chem. Biol. 2013, 8, 1389-1395
16. Marrache, S.; Pathak, R. K.; Dhar, S. Detouring of cisplatin to access mitochondrial genome for overcoming resistance Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 10444-10449
17. Galluzzi, L.; Senovilla, L.; Vitale, I.; Michels, J.; Martins, I.; Kepp, O.; Castedo, M.; Kroemer, G. Molecular mechanisms of cisplatin resistance Oncogene 2012, 31, 1869-1883
18. Yu, Z. W.; Zhong, L. P.; Ji, T.; Zhang, P.; Chen, W. T.; Zhang, C. P. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines Oral Oncol. 2010, 46, 317-322
19. Gagnon, V.; Mathieu, I.; Sexton, E.; Leblanc, K.; Asselin, E. AKT involvement in cisplatin chemoresistance of human uterine cancer cells Gynecol. Oncol. 2004, 94, 785-795
20. Yang, Z.; Schumaker, L. M.; Egorin, M. J.; Zuhowski, E. G.; Guo, Z.; Cullen, K. J. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis Clini. Cancer Res. 2006, 12, 5817-5825
21. Kalayda, G. V.; Zhang, G.; Abraham, T.; Tanke, H. J.; Reedijk, J. Application of Fluorescence Microscopy for Investigation of Cellular Distribution of Dinuclear Pt Anticancer Drugs J. Med. Chem. 2005, 48, 5191-5202
22. Liang, X. J.; Finkel, T.; Shen, D. W.; Yin, J. J.; Aszalos, A.; Gottesman, M. M. SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism Mol. Cancer Res. 2008, 6, 1499-1506
23. Katano, K.; Safaei, R.; Samimi, G.; Holzer, A.; Tomioka, M.; Goodman, M.; Howell, S. B. Confocal Microscopic Analysis of the Interaction between Cisplatin and the Copper Transporter ATP7B in Human Ovarian Carcinoma Cells Clin. Cancer Res. 2004, 10, 4578-4588
24. Li, Z.; Zheng, M.; Guan, X.; Xie, Z.; Huang, Y.; Jing, X. Unadulterated BODIPY-dimer nanoparticles with high stability and good biocompatibility for cellular imaging Nanoscale 2014, 6, 5662-5665
25. Quan, L.; Liu, S.; Sun, T.; Guan, X.; Lin, W.; Xie, Z.; Huang, Y.; Wang, Y.; Jing, X. Near-infrared emitting fluorescent BODIPY nanovesicles for in vivo molecular imaging and drug delivery ACS Appl. Mater. Interfaces 2014, 6, 16166-16173
26. Miller, M. A.; Askevold, B.; Yang, K. S.; Kohler, R. H.; Weissleder, R. Pt Compounds for High-Resolution In Vivo Cancer Imaging ChemMedChem. 2014, 9, 1131-1135
27. Bartelmess, J.; Weare, W. W.; Latortue, N.; Duong, C.; Jones, D. S. meso-Pyridyl BODIPYs with tunable chemical, optical and electrochemical properties New J. Chem. 2013, 37, 2663-2668
28. Park, G. Y.; Wilson, J. J.; Song, Y.; Lippard, S. J. Phenanthriplatin, a monofunctional DNA-binding Pt anticancer drug candidate with unusual potency and cellular activity profile Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 11987-11992
29. Ulrich, G.; Ziessel, R. Convenient and Efficient Synthesis of Functionalized Oligopyridine Ligands Bearing Accessory Pyrromethene-BF2 Fluorophores J. Org. Chem. 2004, 69, 2070-2083
30. Olmsted, J. Calorimetric determinations of absolute fluorescence quantum yields J. Phys. Chem. 1979, 83, 2581-2584
31. Zhu, Z.; Wang, X.; Li, T.; Aime, S.; Sadler, P. J.; Guo, Z. Pt(II)-Gadolinium(III) Complexes as Potential Single-Molecular Theranostic Agents for Cancer Treatment Angew. Chem. 2014, 53, 13225-13228
32. Yuan, H.; Cho, H.; Chen, H. H.; Panagia, M.; Sosnovik, D. E.; Josephson, L. Fluorescent and radiolabeled triphenylphosphonium probes for imaging mitochondria Chem. Commun. 2013, 49, 10361-10363
33. Leung, C. W.; Hong, Y.; Chen, S.; Zhao, E.; Lam, J. W.; Tang, B. Z. A photostable AIE luminogen for specific mitochondrial imaging and tracking J. Am. Chem. Soc. 2013, 135, 62-65
34. Li, J.; Hu, X.; Liu, M.; Hou, J.; Xie, Z.; Huang, Y.; Jing, X. Complex of cisplatin with biocompatible poly(ethylene glycol) with pendant carboxyl groups for the effective treatment of liver cancer J. Appl. Polym. Sci. 2014, 131, 40764
35. Xiao, H.; Song, H.; Yang, Q.; Cai, H.; Qi, R.; Yan, L.; Liu, S.; Zheng, Y.; Huang, Y.; Liu, T.; Jing, X. A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance Biomaterials 2012, 33, 6507-6519